ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

MENOMUNE-A/C/Y/W-135
Vaccines
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

MENOMUNE-A/C/Y/W-135 Rx

Generic Name and Formulations:
Neisseria meningitidis polysaccharides 50mcg; each of Group A, C, Y, and W-135 per 0.5mL; pwd for SC inj after reconstitution.

Company:
Sanofi Pasteur, Inc.

Therapeutic Use:

Indications for MENOMUNE-A/C/Y/W-135:

Meningitis immunization.

Adults and Children:

<2yrs: not recommended (except as short-term protection in infants ≥3months of age against Group A). ≥2yrs: 0.5 mL SC once. If still at high risk, may revaccinate children first vaccinated at <4yrs of age after 2–3yrs, and older children and adults after 3–5yrs.

Contraindications:

Acute illness.

Warnings/Precautions:

Immunodeficiency. Have epinephrine inj (1:1000) available. Latex allergy. Pregnancy (Cat.C). Nursing mothers.

Interactions:

Do not give with whole-cell pertussis or whole-cell typhoid vaccines. Immunosuppressants: may get suboptimal response.

Adverse Reactions:

Tenderness, erythema, or pain at inj site; headache, malaise, chills, fever.

How Supplied:

Single-dose vials—1, 5 (preservative-free diluent); Multidose vial—1 (thimerosal-preserved diluent)

Sign Up for Free e-Newsletters

CME Focus